|XNBI -- USA Index|| |
3,413 15.43 0.45%
As of 20 of September NASDAQ Biotechnology secures Mean Deviation
of 0.7553. Macroaxis technical analysis interface lets you check practical technical drivers
of NASDAQ Biotechnology
as well as the relationship between them. Strictly speaking you can use this information to find out if the entity will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers
for NASDAQ Biotechnology which can be compared to its peers in the industry. Please verify NASDAQ Biotechnology Information Ratio
, and the relationship
between Downside Deviation
and Value At Risk
to decide if NASDAQ Biotechnology Total Retu is priced more or less accurately providing market reflects its recent price of 3412.57 per share.
NASDAQ Biotechnology Trend Analysis
Use this graph to draw trend lines for NASDAQ Biotechnology Total Retu. You can use it to identify possible trend reversals for NASDAQ Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NASDAQ Biotechnology price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
NASDAQ Biotechnology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NASDAQ Biotechnology Total Retu applied against its price change over selected period. The best fit line has a slop of 9.36 %
which means NASDAQ Biotechnology Total Retu will continue producing value for investors. It has 20 observation points and a regression sum of squares at 14447.35, which is the sum of squared deviations for the predicted NASDAQ Biotechnology price change compared to its average price change.